Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies

European Journal of Epidemiology

Volumn 26, Issue 7, 2011, Pages 511-525

  Golden, Sherita Hill ^a,b   Wand, Gary S ^a   Malhotra, Saurabh ^c   Kamel, Ihab ^a   Horton, Karen ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal gland volume; Cortisol awakening response; Cortisol diurnal curve; Dexamethasone suppression test; Reliability; Salivary cortisol

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ACCURACY; ADRENAL GLAND; ANALYTIC METHOD; AREA UNDER THE CURVE; BODY MASS; CHRONIC STRESS; CIRCADIAN RHYTHM; COMPUTER ASSISTED TOMOGRAPHY; DEXAMETHASONE SUPPRESSION TEST; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HORMONAL REGULATION; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMAGE ANALYSIS; MEDICAL LITERATURE; METABOLIC DISORDER; NEGATIVE FEEDBACK; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREDICTION; RELIABILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALIVA ANALYSIS; SYSTEMATIC REVIEW;

ADRENAL GLANDS; ALLOSTASIS; CIRCADIAN RHYTHM; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; REPRODUCIBILITY OF RESULTS; SALIVA;

EID: 79961009397     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-011-9585-2     Document Type: Review

References (49)

1. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873-904. (Pubitemid 47086281)
2. Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35:2-16.
3. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 2002;23:51-61. (Pubitemid 34687133)
4. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31:2383-90.
5. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Roux AV, Lee HB, Lyketsos C. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751-9. (Pubitemid 351846850)
6. Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diabetes Rev. 2007;3:252-9. (Pubitemid 350111108)
7. Szklo M, Nieto FJ. Quality assurance and control. Epidemiology beyond the Basics. Sudbury: Jones and Bartlett Publishers; 2004. pp. 343-404.
8. Derr RL, Cameron SJ, Golden SH. Pre-analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research. Eur J Epidemiol. 2006;21:217-26.
9. Hellhammer DH, Wust S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34:163-71.
10. Raff H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J Clin Endocrinol Metab. 2009;94:3647-55.
11. Groschl M, Rauh M. Influence of commercial collection devices for saliva on the reliability of salivary steroids analysis. Steroids. 2006;71:1097-100. (Pubitemid 44792167)
12. Garde AH, Hansen AM. Long-term stability of salivary cortisol. Scand J Clin Lab Invest. 2005;65:433-6. (Pubitemid 41134091)
13. Levine A, Zagoory-Sharon O, Feldman R, Lewis JG, Weller A. Measuring cortisol in human psychobiological studies. Physiol Behav. 2007;90:43-53. (Pubitemid 44918006)
14. Broderick JE, Arnold D, Kudielka BM, Kirschbaum C. Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology. 2004;29:636-50. (Pubitemid 38369167)
15. Badrick E, Kirschbaum C, Kumari M. The relationship between smoking status and cortisol secretion. J Clin Endocrinol Metab. 2007;92:819-24. (Pubitemid 46465649)
16. Granger DA, Hibel LC, Fortunato CK, Kapelewski CH. Medication effects on salivary cortisol: tactics and strategy to minimize impact in behavioral and developmental science. Psychoneuroendocrinology. 2009;34:1437-48.
17. Coste J, Strauch G, Letrait M, Bertagna X. Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology. Br J Clin Pharmacol. 1994;38:474-9. (Pubitemid 24344038)
18. Harris TO, Borsanyi S, Messari S, Stanford K, Cleary SE, Shiers HM, Brown GW, Herbert J. Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br J Psychiatr. 2000;177:505-10. (Pubitemid 32005480)
19. Viardot A, Huber P, Puder JJ, Zulewski H, Keller U, Muller B. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J Clin Endocrinol Metab. 2005;90:5730-6. (Pubitemid 41415483)
20. Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodini I. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol. 2009;160:87-92.
21. Pruessner JC, Wolf OT, Hellhammer DH, Buske-Kirschbaum A, von Auer K, Jobst S, Kaspers F, Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997;61:2539-49. (Pubitemid 28035578)
22. Edwards S, Clow A, Evans P, Hucklebridge F. Exploration of the awakening cortisol response in relation to diurnal cortisol secretory activity. Life Sci. 2001;68:2093-103. (Pubitemid 32289391)
23. Kraemer HC, Giese-Davis J, Yutsis M, O'Hara R, Neri E, Gallagher-Thompson D, Taylor CB, Spiegel D. Design decisions to optimize reliability of daytime cortisol slopes in an older population. Am J Geriatr Psychiatr. 2006;14:325-33.
24. Ranjit N, Diez-Roux AV, Sanchez B, Seeman T, Shea S, Shrager S, Watson K. Association of salivary cortisol circadian pattern with cynical hostility: multi-ethnic study of atherosclerosis. Psychosom Med. 2009;71:748-55.
25. Hruschka DJ, Kohrt BA, Worthman CM. Estimating between- and within-individual variation in cortisol levels using multilevel models. Psychoneuroendocrinology. 2005;30:698-714. (Pubitemid 40613018)
26. Knutsson U, Dahlgren J, Marcus C, Rosberg S, Bronnegard M, Stierna P, Albertsson-Wikland K. Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development. J Clin Endocrinol Metab. 1997;82:536-40. (Pubitemid 27068625)
27. Schmidt-Reinwald A, Pruessner JC, Hellhammer DH, Federenko I, Rohleder N, Schurmeyer TH, Kirschbaum C. The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci. 1999;64:1653-60. (Pubitemid 29185346)
28. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593-602. (Pubitemid 38033020)
29. Ljung T, Andersson B, Bengtsson BA, Bjorntorp P, Marin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes Res. 1996;4:277-82. (Pubitemid 126690231)
30. Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab. 1998;83:47-54. (Pubitemid 28498309)
31. Golden SH, Malhotra S, Wand GS, Brancati FL, Ford D, Horton K. Adrenal gland volume and dexamethasone-suppressed cortisol correlate with total daily salivary cortisol in African-American women. J Clin Endocrinol Metab. 2007;92:1358-63. (Pubitemid 46556410)
32. Yanovski SZ, Yanovski JA, Gwirtsman HE, Bernat A, Gold PW, Chrousos GP. Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. J Clin Endocrinol Metab. 1993;76:675-9. (Pubitemid 23086486)
33. Wingenfeld K, Lange W, Wulff H, Berea C, Beblo T, Saavedra AS, Mensebach C, Driessen M. Stability of the dexamethasone suppression test in borderline personality disorder with and without comorbid PTSD: a one-year follow-up study. J Clin Psychol. 2007;63:843-50. (Pubitemid 47435180)
34. Reynolds RM, Bendall HE, Whorwood CB, Wood PJ, Walker BR, Phillips DI. Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays. Clin Endocrinol (Oxf). 1998;49:307-10. (Pubitemid 28448939)
35. Gozansky WS, Lynn JS, Laudenslager ML, Kohrt WM. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity. Clin Endocrinol (Oxf). 2005;63:336-41. (Pubitemid 41233453)
36. Harris B, Watkins S, Cook N, Walker RF, Read GF, Riad-Fahmy D. Comparisons of plasma and salivary cortisol determinations for the diagnostic efficacy of the dexamethasone suppression test. Biol Psychiatr. 1990;27:897-904. (Pubitemid 20145677)
37. Imaki T, Naruse M, Takano K. Adrenocortical hyperplasia associated with ACTH-dependent Cushing's syndrome: comparison of the size of adrenal glands with clinical and endocrinological data. Endocr J. 2004;51:89-95. (Pubitemid 38405150)
38. Rubin RT, Phillips JJ, Sadow TF, McCracken JT. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatr. 1995;52:213-8.
39. Cooper MS, Stewart PM. Diagnosis and treatment of ACTH deficiency. Rev Endocr Metab Disord. 2005;6:47-54. (Pubitemid 40558137)
40. Klose M, Lange M, Kosteljanetz M, Poulsgaard L, Feldt-Rasmussen U. Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clin Endocrinol (Oxf). 2005;63:499-505. (Pubitemid 41626743)
41. Rubin RT, Phillips JJ, McCracken JT, Sadow TF. Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function. Biol Psychiatr. 1996;40:89-97. (Pubitemid 26202787)
42. Amsterdam JD, Marinelli DL, Arger P, Winokur A. Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study. Psychiatr Res. 1987;21:189-97. (Pubitemid 17097010)
43. Brauckhoff M, Stock K, Stock S, Lorenz K, Sekulla C, Brauckhoff K, Thanh PN, Gimm O, Spielmann RP, Dralle H. Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy. World J Surg. 2008;32:863-72.
44. Grant LA, Napolitano A, Miller S, Stephens K, McHugh SM, Dixon AK. A pilot study to assess the feasibility of measurement of adrenal gland volume by magnetic resonance imaging. Acta Radiol. 2010;51:117-20.
45. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94:2692-701.
46. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatr. 1983;40:493-500.
47. Holsboer F, Liebl R, Hofschuster E. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. J Affect Disord. 1982;4:93-101. (Pubitemid 12076970)
48. Heuser I, Yassouridis A, Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res. 1994;28:341-56. (Pubitemid 24370022)
49. Kunzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology. 2003;28:2169-78. (Pubitemid 37468184)